Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...

Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into immune cells and remains for the duration.

A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together with the Schief ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Antibodies are small proteins that are secreted by specialized cells to target and neutralize pathogens. The “Y” shaped structure is crucial fo | Immunology ...

Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated ...

An antibody (teal) bound to its target, the HIV protein Env (white and gray), also attaches to an immune cell via a receptor (red) on the immune cell’s surface. This interaction can activate the ...

Predicting how circulating immune cells interact with human tissues remains a major challenge in preclinical drug testing. Traditional static culture systems often allow suspended cells to settle, ...

Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, and only a small fraction reach the five-year mark. Treatments that succeed ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...